BRPI0823193A2 - inibidores de protease de bowman birk variantes modificados - Google Patents
inibidores de protease de bowman birk variantes modificadosInfo
- Publication number
- BRPI0823193A2 BRPI0823193A2 BRPI0823193A BRPI0823193A BRPI0823193A2 BR PI0823193 A2 BRPI0823193 A2 BR PI0823193A2 BR PI0823193 A BRPI0823193 A BR PI0823193A BR PI0823193 A BRPI0823193 A BR PI0823193A BR PI0823193 A2 BRPI0823193 A2 BR PI0823193A2
- Authority
- BR
- Brazil
- Prior art keywords
- protease inhibitors
- modified variant
- bowman birk
- birk protease
- variant bowman
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2008/079951 WO2010044786A1 (en) | 2008-10-15 | 2008-10-15 | Modified variant bowman birk protease inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0823193A2 true BRPI0823193A2 (pt) | 2019-09-24 |
Family
ID=40548632
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0823193A BRPI0823193A2 (pt) | 2008-10-15 | 2008-10-15 | inibidores de protease de bowman birk variantes modificados |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP2344531B1 (pt) |
| JP (1) | JP5740308B2 (pt) |
| CN (1) | CN102245635B (pt) |
| AU (1) | AU2008362898B2 (pt) |
| BR (1) | BRPI0823193A2 (pt) |
| CA (1) | CA2740197A1 (pt) |
| MX (1) | MX2011003803A (pt) |
| RU (1) | RU2509776C2 (pt) |
| WO (1) | WO2010044786A1 (pt) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112012016232A2 (pt) * | 2009-12-30 | 2017-03-07 | Solae Llc | processo para separação e purificação de um produto de kti |
| WO2011161135A1 (en) | 2010-06-22 | 2011-12-29 | Novozymes A/S | Enzyme dehairing of skins and hides |
| WO2012149333A1 (en) | 2011-04-29 | 2012-11-01 | Danisco Us Inc. | Detergent compositions containing bacillus sp. mannanase and methods of use thereof |
| AR086214A1 (es) | 2011-04-29 | 2013-11-27 | Danisco Us Inc | Composiciones detergentes que contienen mananasa de bacillus agaradhaerens y sus metodos de uso |
| EP2712363A1 (en) | 2011-04-29 | 2014-04-02 | Danisco US Inc. | Detergent compositions containing geobacillus tepidamans mannanase and methods of use thereof |
| WO2014100018A1 (en) | 2012-12-19 | 2014-06-26 | Danisco Us Inc. | Novel mannanase, compositions and methods of use thereof |
| CN103710373B (zh) * | 2013-12-31 | 2016-03-30 | 中山大学 | 一种原核融合表达载体及其应用 |
| CN106317185B (zh) * | 2015-06-23 | 2019-09-17 | 首都医科大学 | His-Gly-Tyr-Asp，其合成，活性和应用 |
| EP4141113A1 (en) | 2015-11-05 | 2023-03-01 | Danisco US Inc | Paenibacillus sp. mannanases |
| JP7364330B2 (ja) | 2015-11-05 | 2023-10-18 | ダニスコ・ユーエス・インク | パエニバチルス（Ｐａｅｎｉｂａｃｉｌｌｕｓ）属種及びバチルス（Ｂａｃｉｌｌｕｓ）属種のマンナナーゼ |
| EP3429612A4 (en) * | 2016-03-16 | 2020-04-08 | AmideBio LLC | METHODS OF PRODUCING PEPTIDES AND USES THEREOF |
| CN109689022B (zh) * | 2016-09-13 | 2022-06-14 | 巴斯夫欧洲公司 | 低分子量角蛋白水解物 |
| CN108424931A (zh) * | 2018-03-29 | 2018-08-21 | 内蒙古大学 | CRISPR/Cas9技术介导山羊VEGF基因定点整合的方法 |
| CN112553274B (zh) * | 2020-12-02 | 2023-06-13 | 江南大学 | 大豆提取物Bowman-Birk inhibitor切割DNA的方法 |
| WO2024050339A1 (en) | 2022-09-02 | 2024-03-07 | Danisco Us Inc. | Mannanase variants and methods of use |
| CN116694606B (zh) * | 2023-06-21 | 2024-03-26 | 江南大学 | 一种利用角蛋白酶水解玉米黄粉醇溶蛋白的方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3119383A1 (de) | 1981-05-15 | 1982-12-02 | Basf Ag, 6700 Ludwigshafen | Verfahren zur herstellung von feinverteilten, pulverfoermigen carotinodpraeparaten |
| US5411873A (en) | 1984-05-29 | 1995-05-02 | Genencor, Inc. | Process for producing heterologous polypeptides |
| US5679543A (en) | 1985-08-29 | 1997-10-21 | Genencor International, Inc. | DNA sequences, vectors and fusion polypeptides to increase secretion of desired polypeptides from filamentous fungi |
| US5429950A (en) | 1992-03-30 | 1995-07-04 | Genencor International, Inc. | Heterologous gene expression in bacillus subtilis: fusion approach |
| IL120310A (en) * | 1996-03-01 | 2002-02-10 | Akzo Nobel Nv | Serine protease inhibitors and pharmaceuticals containing them |
| ATE282703T1 (de) | 1996-03-12 | 2004-12-15 | Genencor Int | Alkalische cellulase und verfahren zu deren herstellung |
| US6835550B1 (en) | 1998-04-15 | 2004-12-28 | Genencor International, Inc. | Mutant proteins having lower allergenic response in humans and methods for constructing, identifying and producing such proteins |
| NZ509013A (en) * | 1998-07-20 | 2002-12-20 | Inoxell As | Novel methods for the identification of ligand and target biomolecules |
| US20020098524A1 (en) | 2000-04-14 | 2002-07-25 | Murray Christopher J. | Methods for selective targeting |
| US6537968B1 (en) | 2000-07-24 | 2003-03-25 | Alphamed Pharmaceuticals Corp | Treatment of lupus erythematosus |
| ATE482972T1 (de) | 2003-11-06 | 2010-10-15 | Danisco Us Inc | Tgf-beta1-bindende und geträgerte peptide |
| EP1689766B1 (en) * | 2003-11-06 | 2012-04-25 | Danisco US Inc. | Expression in filamentous fungi of protease inhibitors and variants thereof |
| US9084734B2 (en) * | 2005-05-05 | 2015-07-21 | Danisco Us Inc. | Peptide personal care compositions and methods for their use |
| EP1982042B1 (en) | 2006-01-24 | 2018-07-04 | Helix Well Ops (U.K.) Limited | Bore selector |
| GB0601684D0 (en) * | 2006-01-27 | 2006-03-08 | Reckitt Benckiser Uk Ltd | Composition, process for preparation and method of use |
-
2008
- 2008-10-15 BR BRPI0823193A patent/BRPI0823193A2/pt not_active IP Right Cessation
- 2008-10-15 RU RU2011119481/10A patent/RU2509776C2/ru not_active IP Right Cessation
- 2008-10-15 WO PCT/US2008/079951 patent/WO2010044786A1/en not_active Ceased
- 2008-10-15 AU AU2008362898A patent/AU2008362898B2/en not_active Ceased
- 2008-10-15 CA CA2740197A patent/CA2740197A1/en not_active Abandoned
- 2008-10-15 JP JP2011532052A patent/JP5740308B2/ja not_active Expired - Fee Related
- 2008-10-15 EP EP08876414.7A patent/EP2344531B1/en not_active Not-in-force
- 2008-10-15 MX MX2011003803A patent/MX2011003803A/es active IP Right Grant
- 2008-10-15 CN CN200880132330.9A patent/CN102245635B/zh not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP5740308B2 (ja) | 2015-06-24 |
| RU2011119481A (ru) | 2012-11-27 |
| CA2740197A1 (en) | 2010-04-22 |
| MX2011003803A (es) | 2011-07-04 |
| CN102245635B (zh) | 2016-08-31 |
| EP2344531A1 (en) | 2011-07-20 |
| WO2010044786A1 (en) | 2010-04-22 |
| EP2344531B1 (en) | 2014-12-10 |
| CN102245635A (zh) | 2011-11-16 |
| AU2008362898A1 (en) | 2010-04-22 |
| RU2509776C2 (ru) | 2014-03-20 |
| AU2008362898B2 (en) | 2013-02-28 |
| JP2012505652A (ja) | 2012-03-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0823193A2 (pt) | inibidores de protease de bowman birk variantes modificados | |
| CY2020023I1 (el) | Αναστολεiς βητα-λακταμασων | |
| LTPA2017010I1 (lt) | Proteazomos inhibitoriai | |
| BRPI0807547A2 (pt) | Inibidores de aspartil protease hetercíclicos | |
| EP2477980A4 (en) | HCV Protease Inhibitors | |
| EP2305306A4 (en) | NEURO INVASION INHIBITOR | |
| DK2408758T3 (da) | Krystallin tripeptid-epoxy-keton-protease-inhibitorer | |
| BRPI1011267A2 (pt) | inibidores de protease | |
| BRPI0922084A2 (pt) | Composições e métodos compreendendo variantes de serina protease | |
| ZA201008988B (en) | Hcv protease inhibitors | |
| BRPI0918564A2 (pt) | inibidores | |
| BR112012001070A2 (pt) | inibidores de ativação de complementos | |
| BR112012005382A2 (pt) | inibidores de jak | |
| EP2307345A4 (en) | NON-PEPTIDINHIBITORS OF HIV-1 PROTEASE | |
| BRPI0922283A2 (pt) | inibidores da cistéina protease | |
| EP2313426A4 (en) | NEW PROTEASE INHIBITORS | |
| BRPI0918966A2 (pt) | inibidores de protease | |
| BRPI0921201A2 (pt) | válvula de expansão compreendendo meios de polarização | |
| BRPI0813763A2 (pt) | Inibidores da protease de cisteína | |
| BRPI0919073A2 (pt) | inibidores de protease | |
| BR112012003044A2 (pt) | inibidores de catepsina c. | |
| EP2400976A4 (en) | GENTLE PROTEASE INHIBITORS AND PRO-SOFT FORMS | |
| TH101958B (th) | สารยับยั้งแอสพาร์ติค โปรติเอส | |
| EP2168954A4 (en) | CYSTEINE PROTEASES INHIBITORS | |
| TH0801000834A (th) | ตัวยับยั้งเฮเทอโรไซคลิก แอสพาร์ทิลโปรตีเอส |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application fees: dismissal - article 86 of industrial property law | ||
| B08K | Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87) |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |